WASHINGTON & SAN FRANCISCO & SAN DIEGO–(BUSINESS WIRE)–#DrugImportation–California Life Sciences Association (CLSA) Responds To Administration?s Drug Importation Plan […]
Reports + Research BioTime Changes Name and Moves to Carlsbad BioTime changed its name to Lineage Cell Therapeutics (NYSE: LCTX) and is relocating its corporate headquarters to Carlsbad in mid-August. Lineage Cell Therapeutics develops cell therapies f… […]
BioTime, which has three cell therapies in human testing, is relocating its corporate headquarters from Alameda in the San Francisco Bay Area to Carlsbad. […]
About this time last year, DNA sequencing giant Illumina upped its financial projections, estimating its sales would grow 20 percent year-over-year. It exceeded that goal, with revenue rising 21 percent to $3.33 billion by the end of 2018. It?s a diffe… […]
U.S. News & World Report. The annual ?Best Hospitals? rankings are designed to assist patients and their doctors in making informed decisions about where to receive care for challenging health conditions. ]]>
… […]
LA JOLLA?Neurodevelopmental disorders arising from rare genetic mutations can cause atypical cognitive function, intellectual disability, and developmental delays, yet it is unclear why and how this happens.?Scientists suspected a mutation in a complex… […]
SAN DIEGO–(BUSINESS WIRE)–$ILMN #ILMN–Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the second quarter of fiscal year 2019. Second quarter 2019 results: Revenue of $838 million, a 1% increase compared to $830 million in the… […]
As predicted by Bloomberg, cancer diagnostics company Exact Sciences is buying peer Genomic Health in a?$2.8 billion cash-and-stock deal.?
Exact Sciences? flagship colorectal cancer test Cologuard will complement Genomic Health?s Oncotype DX, a test de… […]
Once disregarded as waste, exosomes now are known as important cellular messengers. Scripps Research study illuminates their role in brain health […]
LA JOLLA?(July 26, 2019) The vast majority of deadly lung cancer cases (85 percent) are termed non-small-cell lung carcinomas (NSCLCs), which often contain a mutated gene called LKB1. Salk Institute researchers have now discovered precisely why inactiv… […]
CARLSBAD, Calif., July 25, 2019 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Canacc… […]
LA JOLLA, Calif., July 25, 2019 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient?s innate immune system to fight disease, today announced that C.J. Barnum, Director o… […]
Christina Waters is the CEO and president of RARE Science. The mission is?to identify more immediate therapeutic solutions for kids with rare diseases. There may be 7-8000 rare diseases, but because of their rarity, they […]
SAN DIEGO–(BUSINESS WIRE)–ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended June 30, 2019. Fourth Quarter 2019 Highlights Revenue increased 13% to $705.0 million; up 15% on a co… […]
LA JOLLA, Calif., July 24, 2019 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the appointment… […]
Reports + Research Cradle Genomics Raises $17 Million for More Comprehensive Prenatal Tests The $17.1 million Series A financing was led by Illumina Ventures and Section 32 with participation from Alexandria Real Estate Equities, Sea Lane Ventures, Lis… […]
SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obe… […]
SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) — Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, announced today it has opened HAMMER, a global, Phase 1/2, first… […]
Many medicines used today?including aspirin, penicillin and malaria-fighting quinine?originated from nature. Now, Sanford Burnham Prebys and UC San Diego scientists have turned to ancient digestive herbs to learn about gut health?in the hopes of uncove… […]
The first business accelerator program in southeast San Diego is accepting applications for its second cohort of entrepreneurs, who would start the program in fall. The six-month program, Connect All, is run by Connect, a longstanding local organizatio… […]
LA JOLLA?Around 85 percent of lung cancers are classified as non-small-cell lung cancers, or NSCLCs. Some patients with these cancers can be treated with targeted genetic therapies, and some benefit from immunotherapies?but the vast majority of NSCLC p… […]
At Takeda, one of the top priorities in the R&D group since the $62 billion acquisition of Shire closed at the beginning of the year has been centered on creating a shared culture ? and that calls for some group activities.?
Six weeks after the dea… […]
SAN DIEGO and TORONTO, July 23, 2019 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes and signaling pathways of cancer… […]
With another trial failure, it might be time for the FDA to revoke the approval of Acadia Pharma?s anti-psychosis drug. […]
HireAHelper.com, an online marketplace that links people who are moving to a new home with local movers and related services, has been acquired by Porch, which operates a marketplace that connects people with a variety of home repair and improvement se… […]
CARLSBAD, Calif., July 22, 2019 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close on?Monday, August 5, 2019. Management will hold a conference … […]
SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of ob… […]
Copyright © 2023 Biotech Networks, LLC
